Stop Leading with Data, Start Leading with Impact: How to Secure Saudi Funding for Your Biotech

In the Kingdom, investment decisions are increasingly shaped by long-term national priorities aligned with Saudi Vision 2030 and the National Biotechnology Strategy. Investors are not only evaluating financial returns, but also how a company can contribute to building domestic capability, improving patient access, and strengthening healthcare infrastructure. This session will explore how biotech companies can reposition their value proposition to align with Saudi Arabia's strategic goals ' from enabling clinical trials in the Kingdom and transferring knowledge, to supporting workforce development and local manufacturing. We'll unpack what Saudi investors are truly looking for, where founders often go wrong, and how to move from a data-led pitch to an impact-driven partnership."